Management of Systematic Lupus Erythematosus

Case 1 New-Onset Arthritic Flare

Initial Assessment in Primary Care

Medication Nonadherence in SLE

Therapeutic Drug Monitoring to Measure Nonadherence

Identifying Patients at Increased Risk for Flare and Persistently Active Disease

Laboratory Assessments in Patients With SLE

Measuring Disease Activity in the Clinic

Initial Approach Increase Steroid Dose

Maximizing Benefit From Steroid Use

HCQ Use in SLE

Case 1 Follow-up in Primary Care

Nonbiologic Immunosuppressive Therapy

Belimumab Efficacy

Belimumab Safety

Considerations for Treatment Selection and Monitoring

Additional Considerations for Women of Childbearing Age

Case 2 Recognizing Complications of SLE

Case 2 Management Considerations

Case 3 Concerns About Steroid Side Effects

Quantifying Adverse Effects of Steroid Use

Approaches to Minimize Risks of Steroid Use

Importance of Engaging the Patient in the SLE Management Plan

Looking Ahead Ongoing Challenges in the Management of SLE

Abbreviations

Abbreviations (cont)